Does DURVALUMAB Cause Dermatitis exfoliative generalised? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Dermatitis exfoliative generalised have been filed in association with DURVALUMAB (IMFINZI). This represents 0.0% of all adverse event reports for DURVALUMAB.
7
Reports of Dermatitis exfoliative generalised with DURVALUMAB
0.0%
of all DURVALUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From DURVALUMAB?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which DURVALUMAB Alternatives Have Lower Dermatitis exfoliative generalised Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE